ANDREW GARZA: Open Payments
NPI 1104561281 · DALLAS, TX. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$29,577 in 368 payments from 30 companies in 2025. Trend: 2023 $5,133 · 2024 $6,447 · 2025 $29,577
Speaker / faculty: $19,995Food & beverage: $6,005Travel & lodging: $2,458Speaker / faculty: $460Consulting: $425Education: $234
| Company | Payments | Amount |
|---|---|---|
| Insulet Corporation | 44 | $16,694 |
| Medtronic, Inc. | 46 | $6,455 |
| Corcept Therapeutics | 37 | $1,536 |
| Abbott Laboratories | 20 | $953 |
| Amgen Inc. | 55 | $897 |
| Xeris Pharmaceuticals, Inc. | 23 | $371 |
| Sequel Med Tech, LLC | 16 | $364 |
| Bayer Healthcare Pharmaceuticals Inc. | 33 | $348 |
| BETA BIONICS, INC. | 7 | $319 |
| Novo Nordisk Inc | 16 | $281 |
Products named: OMNIPOD, MINIMED 780G, Korlym, EVENITY, FREESTYLE LIBRE, FREESTYLE LIBRE 3, TWIIST, Kerendia.
Industry payments across TX — which companies pay providers there.
